⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FDMT News
4D Molecular Therapeutics, Inc. Common Stock
4DMT to Participate in Upcoming Investor Meetings
globenewswire.com
FDMT
4DMT to Participate in Upcoming Investor Conferences
globenewswire.com
FDMT
AAV for the Hereditary Retinal Diseases Competitive Landscape Report 2026: Comprehensive Insights About 75+ Companies and 80+ Drugs
globenewswire.com
NVS
JNJ
FDMT
4DMT Announces New Employment Inducement Grants
globenewswire.com
FDMT
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
globenewswire.com
FDMT
4DMT Announces New Employment Inducement Grants
globenewswire.com
FDMT
4DMT Provides Company Update and Anticipated Development Milestones for 2026
globenewswire.com
FDMT
4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease
globenewswire.com
FDMT
4DMT Announces New Employment Inducement Grants
globenewswire.com
FDMT
4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
FDMT